Tesla's stock jumps 4% as Elon Musk makes first visit to China in about three years
By Ciara Linnane
Musk expected to meet with Chinese officials to ensure no disruptions to business in world's biggest EV market
Tesla Inc.'s stock rose 4% on Tuesday, as excitement built about Chief Executive Elon Musk's visit to China, his first in about three years.
Wedbush analyst Dan Ives said the visit comes at a key time for the electric vehicle maker (TSLA) as it braces for the challenge from Chinese EV companies operating in the biggest EV market in the world.
"We would expect Musk to spend most of his visit around the key Shanghai Gigafactory plant which remains the hearts and lungs of the Tesla production globally," Ives wrote in a note to clients.
"With Giga Shanghai now producing over 80k units per month the production scale and scope of Tesla in China remains one of its key advantages as Musk & Co. face increasing domestic competition from the likes of BYD , Nio (NIO), Xpeng (XPEV), and others with an EV price war underway within the country."
Musk is also expected to spend time meeting key officials in Beijing, which may even include Premier Li Qiang, said Ives.
"While the geopolitical tensions between the U.S. and China are increasing, Tesla (as well as Apple (AAPL)) finds itself in a tight wire act to balance its success and production within China which remains a vital market on both the supply and demand front," said the analyst.
"Playing nice in the sandbox in Beijing is something the Street is laser focused on to make sure there are no disruptions to Tesla's expansion and tentacles within China for the coming years as this remains the number 1 EV market in the world."
Ives had an outperform rating on Tesla stock, the equivalent of buy. His $215 price target is about 11% above its current price.
Tesla stock has gained 57% in the year to date, while the S&P 500 has gained 9.5%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-30-23 0937ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth
-
10 Best Blue-Chip Stocks to Buy for the Long Term
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
ServiceNow Earnings: Strong Quarter With In-Line Guidance and Increasingly Attractive Valuation
-
Ford Earnings: Pro Continues to Impress While EV Costs Are Contained
-
Boeing Earnings: Paying for Mistakes Made Long Ago, Taking Back the Factory Floor
-
Meta Earnings: Stock Now Fairly Valued After Latest Selloff
-
March PCE Inflation Index Forecasts Show Mixed Readings On Price Pressures